Valuation: Victrex plc

Market Cap 707M 958M 827M 776M 1.33B 91.64B 1.35B 9.1B 3.57B 45.91B 3.6B 3.52B 153B P/E 2026 *
-141x
P/E 2027 * 17.6x
Enterprise Value 749M 1.01B 876M 822M 1.41B 97.05B 1.43B 9.64B 3.78B 48.62B 3.81B 3.73B 162B EV / Sales 2026 *
2.51x
EV / Sales 2027 * 2.44x
Free-Float
99.14%
Yield 2026 *
7.34%
Yield 2027 * 7.34%
1 day+12.53%
3 months+12.53%
Current year 3.8
Extreme 3.8
5.3
1 year 3.8
Extreme 3.8
5.3
3 years 3.8
Extreme 3.8
5.3
5 years 3.8
Extreme 3.8
5.3
10 years 3.8
Extreme 3.8
5.3
Manager TitleAgeSince
Chief Executive Officer 53 2025-12-31
Director of Finance/CFO - -
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 67 2018-02-08
Director/Board Member 70 2018-02-08
Director/Board Member 70 2020-04-30
Change 5-day change 1-year change 3-year change Capi.($)
+12.53%-.--% - - 958M
-0.10%-3.01%-1.78%+52.41% 77.33B
-0.93%-3.33%-0.53%-24.40% 37.39B
-0.83%-4.79%-5.62%+14.76% 36.29B
-1.85%-0.50%-11.49%+17.42% 24.33B
-0.29%-2.55%+28.57%+19.72% 22.64B
+1.05%+3.10%+66.59%+17.93% 21.45B
-2.18%+1.07%-34.74%-36.27% 19.32B
-1.59%+2.12%+63.02%-26.65% 15.81B
-0.35%-3.10%+3.34%+78.81% 14.49B
Average +0.61%-1.11%+11.93%+12.64% 29.89B
Weighted average by Cap. -0.60%-1.88%+6.72%+18.40%

Financials

2026 *2027 *
Net sales 299M 405M 349M 328M 561M 38.7B 569M 3.84B 1.51B 19.39B 1.52B 1.49B 64.5B 313M 424M 366M 343M 588M 40.53B 596M 4.02B 1.58B 20.3B 1.59B 1.56B 67.54B
Net income -4.01M -5.44M -4.69M -4.4M -7.54M -520M -7.65M -51.63M -20.23M -260M -20.41M -19.97M -866M 39.36M 53.35M 46.06M 43.21M 74M 5.1B 75.03M 507M 198M 2.56B 200M 196M 8.5B
Net Debt 41.67M 56.49M 48.77M 45.75M 78.36M 5.4B 79.44M 536M 210M 2.71B 212M 207M 9B 55.29M 74.95M 64.7M 60.7M 104M 7.17B 105M 712M 279M 3.59B 281M 275M 11.94B
Logo Victrex plc
Victrex plc is a United Kingdom‑based materials company. The Company manufactures and sells high‑performance polymers and polymer solutions. It develops polyetheretherketone (PEEK) and polyaryletherketone (PAEK) based materials, and produces semi‑finished and finished components, including thermoplastic polymers, engineered parts and biomaterial solutions. It operates across Sustainable Solutions and Medical segments, addressing aerospace, automotive, energy, industrial, electronics and healthcare applications, and provides polymer processing, design support, and material innovation services for implantable and non‑implantable medical devices, as well as industrial and engineering uses. The Company's subsidiaries include Victrex Manufacturing Limited, Invibio Limited, Invibio Knees Limited, Invibio Device Component Manufacturing Limited, and Juvora Limited.
Employees
1,169
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
8.120GBP
Average target price
6.999GBP
Spread / Average Target
-13.80%

Quarterly revenue - Rate of surprise